Progression of Corpus Callosum Atrophy in Early Stage of Alzheimer's Disease. MRI Based Study

Academic Radiology

Volumn 19, Issue 5, 2012, Pages 512-517

  Zhu, Minwei ^a   Gao, Wenpeng ^b   Wang, Xudong ^a   Shi, Chen ^c   Lin, Zhiguo ^a  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b HARBIN INSTITUTE OF TECHNOLOGY   (China)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atrophy; Corpus callosum; Magnetic resonance imaging

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; CONTROLLED STUDY; CORPUS CALLOSUM; CORPUS CALLOSUM ATROPHY; DEMENTIA; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ATROPHY; COMORBIDITY; CORPUS CALLOSUM; DEMENTIA; DISEASE PROGRESSION; FEMALE; HUMANS; INTERNATIONALITY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREVALENCE; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEX DISTRIBUTION;

EID: 84862776693     PISSN: 10766332     EISSN: 18784046     Source Type: Journal    
DOI: 10.1016/j.acra.2012.01.006     Document Type: Article

References (37)

1. Bronge L., Bogdanovic N., Wahlund L.O. Postmortem MRI and histopathology of white matter changes in Alzheimer brains. A quantitative, comparative study. Dement Geriatr Cogn Disord 2002, 13:205-212.
2. Hua X., Leow A.D., Lee S., et al. 3D characterization of brain atrophy in Alzheimer's disease and mild cognitive impairment using tensor-based morphometry. Neuroimage 2008, 41:19-34.
3. Chaim T.M., Duran F.L., Uchida R.R., et al. Volumetric reduction of the corpus callosum in Alzheimer's disease in vivo as assessed with voxel-based morphometry. Psychiatry Res 2007, 154:59-68.
4. Hampel H., Teipel S.J., Alexander G.E., et al. Corpus callosum atrophy is a possible indicator of region- and cell type-specific neuronal degeneration in Alzheimer disease: a magnetic resonance imaging analysis. Arch Neurol 1998, 55:193-198.
5. Hampel H., Teipel S.J., Alexander G.E., et al. In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease. Perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy. Evidence from studies with MRI, EEG and PET. J Neural Transm 2002, 109:837-855.
6. Teipel S.J., Bayer W., Alexander G.E., et al. Regional pattern of hippocampus and corpus callosum atrophy in Alzheimer's disease in relation to dementia severity: evidence for early neocortical degeneration. Neurobiol Aging 2003, 24:85-94.
7. Teipel S.J., Bayer W., Alexander G.E., et al. Progression of corpus callosum atrophy in Alzheimer disease. Arch Neurol 2002, 59:243-248.
8. Teipel S.J., Hampel H., Alexander G.E., et al. Dissociation between corpus callosum atrophy and white matter pathology in Alzheimer's disease. Neurology 1998, 51:1381-1385.
9. Teipel S.J., Hampel H., Pietrini P., et al. Region-specific corpus callosum atrophy correlates with the regional pattern of cortical glucose metabolism in Alzheimer disease. Arch Neurol 1999, 56:467-473.
10. Thomann P.A., Wustenberg T., Pantel J., et al. Structural changes of the corpus callosum in mild cognitive impairment and Alzheimer's disease. Dement Geriatr Cogn Disord 2006, 21:215-220.
11. Tomaiuolo F., Scapin M., Di Paola M., et al. Gross anatomy of the corpus callosum in Alzheimer's disease: regions of degeneration and their neuropsychological correlates. Dement Geriatr Cogn Disord 2007, 23:96-103.
12. Wang P.J., Saykin A.J., Flashman L.A., et al. Regionally specific atrophy of the corpus callosum in AD, MCI and cognitive complaints. Neurobiol Aging 2006, 27:1613-1617.
13. Di Paola M., Luders E., Di Iulio F., et al. Callosal atrophy in mild cognitive impairment and Alzheimer's disease: different effects in different stages. Neuroimage 2010, 49:141-149.
14. Hallam B.J., Brown W.S., Ross C., et al. Regional atrophy of the corpus callosum in dementia. J Int Neuropsychol Soc 2008, 14:414-423.
15. Di Paola M., Di Iulio F., Cherubini A., et al. When, where, and how the corpus callosum changes in MCI and AD: a multimodal MRI study. Neurology 2010, 74:1136-1142.
16. Wang H., Su M.Y. Regional pattern of increased water diffusivity in hippocampus and corpus callosum in mild cognitive impairment. Dement Geriatr Cogn Disord 2006, 22:223-229.
17. Di Paola M., Spalletta G., Caltagirone C. In vivo structural neuroanatomy of corpus callosum in Alzheimer's disease and mild cognitive impairment using different MRI techniques: a review. J Alzheimers Dis 2010, 20:67-95.
18. Morris J.C. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993, 43:2412-2414.
19. Marcus D.S., Wang T.H., Parker J., et al. Open Access Series of Imaging Studies (OASIS): cross-sectional MRI data in young, middle aged, nondemented, and demented older adults. J Cogn Neurosci 2007, 19:1498-1507.
20. Fu Y., Gao W., Zhu M., et al. Computer-assisted automatic localization of the human pedunculopontine nucleus in T1-weighted MR images: a preliminary study. Int J Med Robot 2009, 5:309-318.
21. Hu Q., Nowinski W.L. A rapid algorithm for robust and automatic extraction of the midsagittal plane of the human cerebrum from neuroimages based on local symmetry and outlier removal. Neuroimage 2003, 20:2153-2165.
22. Dempster A.P., Laird D.M., Rubin D.B. Maximum likelihood from incomplete data via the EM algorithm. J R Stat Soc 1977, 39:1-38.
23. Chaudhuri D., Samal A. A simple method for fitting of bounding rectangle to closed regions. Patt Recog 2007, 40:1981-1989.
24. Ryberg C., Rostrup E., Stegmann M.B., et al. Clinical significance of corpus callosum atrophy in a mixed elderly population. Neurobiol Aging 2007, 28:955-963.
25. Witelson S.F. Hand and sex differences in the isthmus and genu of the human corpus callosum. A postmortem morphological study. Brain 1989, 112:799-835.
26. Cummings J.L., Cole G. Alzheimer disease. JAMA 2002, 287:2335-2338.
27. Teipel S.J., Stahl R., Dietrich O., et al. Multivariate network analysis of fiber tract integrity in Alzheimer's disease. Neuroimage 2007, 34:985-995.
28. Zhang Y., Schuff N., Jahng G.H., et al. Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease. Neurology 2007, 68:13-19.
29. Li S., Pu F., Shi F., et al. Regional white matter decreases in Alzheimer's disease using optimized voxel-based morphometry. Acta Radiol 2008, 49:84-90.
30. Salat D.H., Greve D.N., Pacheco J.L., et al. Regional white matter volume differences in nondemented aging and Alzheimer's disease. Neuroimage 2009, 44:1247-1258.
31. Bartzokis G. Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease. Neurobiol Aging 2004, 25:5-18.
32. Braak H., Del Tredici K., Schultz C., et al. Vulnerability of select neuronal types to Alzheimer's disease. Ann N Y Acad Sci 2000, 924:53-61.
33. Tang Y., Nyengaard J.R., Pakkenberg B., et al. Age-induced white matter changes in the human brain: a stereological investigation. Neurobiol Aging 1997, 18:609-615.
34. Aboitiz F., Montiel J. One hundred million years of interhemispheric communication: the history of the corpus callosum. Braz J Med Biol Res 2003, 36:409-420.
35. Aboitiz F., Rodriguez E., Olivares R., et al. Age-related changes in fibre composition of the human corpus callosum: sex differences. Neuroreport 1996, 7:1761-1764.
36. Hofer S., Frahm J. Topography of the human corpus callosum revisited-comprehensive fiber tractography using diffusion tensor magnetic resonance imaging. Neuroimage 2006, 32:989-994.
37. He Q., Christ S.E., Karsch K., et al. Detecting 3D corpus callosum abnormalities in phenylketonuria. Int J Comput Biol Drug Des 2009, 2:289-301.